The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.

Republican politicians have been trying to limit data to only those publicly available, but opponents say that would neglect private, yet important, information.

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.

The use of underperforming computational tools is a major offender in science’s reproducibility crisis—and there’s growing momentum to avoid it.

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

The authors of two new studies on the payments suggest stricter guidelines are needed.

The publisher will ask its journal editors to adopt widely accepted standards on transparency and openness in scientific communication.

Less than half of completed stem cell studies in humans are published in peer-reviewed journals, according to an analysis of regenerative medicine trials. 

Music, the future of American science, and more